Meranda Parascandola - DSI InPharmatics

January 2, 2024

Published by Meranda Parascandola at January 2, 2024

12 Reasons You Should Invest in Biotech Consulting

Biotechnology firms are cropping up all over the place, and growing at an unbelievable rate. California alone is home to over 3,000 life sciences companies, employing over 287,000 people[1] and the global industry is expected to be worth $727.1 billion by 2025.[2]

January 16, 2024

Published by Meranda Parascandola at January 16, 2024

Harmonizing Global CMC Guidelines: A Roadmap to Streamlined Pharmaceutical Approvals

The pharmaceutical industry is growing through global collaboration and market expansion. To continue this growth, regulatory compliance for Chemistry, Manufacturing and Controls (CMC) must be followed. Without CMC regulatory compliance, the safety behind the creation of any products could be compromised. CMC regulatory compliance is a topic that DS Inpharmatics […]

January 17, 2024

Published by Meranda Parascandola at January 17, 2024

U.S. Pharma’s Roadmap to EMA Approval: IMPDs and MAAs Uncovered

Introduction U.S. companies face unique challenges and opportunities in the global race to develop and market new pharmaceuticals. A critical step in this journey is navigating the European Medicines Agency's (EMA) regulatory framework for Investigational Medicinal Product Dossier (IMPD) applications and Marketing Authorization Applications (MAAs). Understanding these processes is key […]

February 9, 2024

Published by Meranda Parascandola at February 9, 2024

The Evolving Role of Data Integrity in Pharmaceutical Quality Assurance

In the realm of pharmaceuticals, data integrity stands as a cornerstone, underpinning the veracity of scientific research, the efficacy of drug development, and the safety of patient outcomes. This critical facet of pharmaceutical quality assurance has evolved significantly, particularly in the wake of advancing technology and stringent regulatory standards. Our […]

March 14, 2024

Published by Meranda Parascandola at March 14, 2024

Strategies for Global Pharmaceutical Supply Chain Excellence: An Interview with Joseph P. Ivan

In this interview, NewsMed spoke with Joseph P. Ivan regarding the Comprehensive Assessment and Management Approach to Optimizing Pharmaceutical Supply Chains. How do you optimize supply chain strategies while navigating the complexities of international regulation guidelines? Navigating international regulations demands the employment of diverse strategies. While consolidating supplies into a […]

March 22, 2024

Published by Meranda Parascandola at March 22, 2024

The Impact of FDA Fast Track and Accelerated Approval on Drug Development

The FDA Fast Track and Accelerated Approval pathways can expedite the review of new drugs. It is important to understand these pathways and how they impact drug development, as well as other industries, like healthcare and pharmaceutics. FDA Fast Track Designation: Accelerating The Time During The Drug Development Process The […]

April 11, 2024

Published by Meranda Parascandola at April 11, 2024

Mastering the Art of Controlled Release: A Journey Through Drug Formulation Complexities. An Interview with Kyriakos Michailaros

Mastering the Art of Controlled Release: A Journey Through Drug Formulation Complexities.An Interview with Kyriakos Michailaros Could you introduce yourself and your expertise in drug development and manufacturing? Following on from my university studies, my career has centered around the development and production of pharmaceuticals. Upon earning my degree in […]

April 25, 2024

Published by Meranda Parascandola at April 25, 2024

Supply Chain Logistics in Pharma: Navigating Complexities for Optimal Delivery

The strength of the pharmaceutical industry relies on the high-quality production of medical products. All areas of the production process are important, from the beginning, when the key components and materials of medications are uncovered, to when they come together as a product and are sent to the patient. The […]

April 29, 2024

Published by Meranda Parascandola at April 29, 2024

Key CMC Considerations for Breakthrough Drug Development

Creating a new drug involves a process that takes a lot of time and effort. When we think about drug development, it can be easy to generalize this procedure and assume that it can be approved rather quickly. However, the timeline for this approval could require you to wait between […]

May 23, 2024

Published by Meranda Parascandola at May 23, 2024

API Processes in the Pharmaceutical Industry

In this interview, NewsMedical talks to Dr. James Mencel’s Guidanceabout Scaling Up API Processes. Could you please introduce yourself and your expertise in the pharmaceutical industry? I earned a Bachelor of Science in Chemistry at Fairfield University in 1979 and a Ph.D. in Organic Chemistry at Yale University in 1984 […]

May 29, 2024

Published by Meranda Parascandola at May 29, 2024

How Supply Chain ERP Transforms Efficiency

By integrating Enterprise Resource Planning (ERP) systems within supply chain management (SCM), there has been a significant evolution in the operational efficiency and agility of business procedures. We aim to explore the transformative impact of supply chain ERP and see how these management systems improve efficiencies. This includes its mechanisms, […]

June 12, 2024

Published by Meranda Parascandola at June 12, 2024

ProductLife Group Announces Comprehensive Solution for Pharmaceutical and Biotechnological Product Development at DIA Conference

Date: June 12, 2024 Location: San Diego, CA ProductLife Group (PLG), a leading provider of product development and compliance services in the pharmaceutical and biotechnological sectors, is excited to announce a comprehensive solution aimed at transforming the landscape of drug development, underscoring PLG's commitment to advancing healthcare through innovation and […]